Acadian Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,156
| Closed | -$63K | – | 1585 |
|
|
2024
Q3 | $63K | Sell |
4,156
-2,728
| -40% | -$41.4K | ﹤0.01% | 1739 |
|
|
2024
Q2 | $111K | Buy |
+6,884
| New | +$111K | ﹤0.01% | 1515 |
|
|
2024
Q1 | – | Sell |
-1,280
| Closed | -$40K | – | 1544 |
|
|
2023
Q4 | $40K | Sell |
1,280
-7,604
| -86% | -$238K | ﹤0.01% | 1484 |
|
|
2023
Q3 | $184K | Buy |
+8,884
| New | +$184K | ﹤0.01% | 1205 |
|
|
2023
Q2 | – | Sell |
-11,628
| Closed | -$218K | – | 1698 |
|
|
2023
Q1 | $218K | Buy |
+11,628
| New | +$218K | ﹤0.01% | 1237 |
|
|
2021
Q3 | – | Sell |
-4,499
| Closed | -$110K | – | 1688 |
|
|
2021
Q2 | $110K | Sell |
4,499
-3,212
| -42% | -$78.5K | ﹤0.01% | 1610 |
|
|
2021
Q1 | $199K | Buy |
7,711
+4,683
| +155% | +$121K | ﹤0.01% | 1503 |
|
|
2020
Q4 | $162K | Buy |
3,028
+2,180
| +257% | +$117K | ﹤0.01% | 1620 |
|
|
2020
Q3 | $35K | Sell |
848
-137
| -14% | -$5.65K | ﹤0.01% | 1942 |
|
|
2020
Q2 | $48K | Buy |
+985
| New | +$48K | ﹤0.01% | 1928 |
|